You are here
- Home
- Therapy Areas
- Oncology/Infection
A Randomised Open-Label Phase IIa Study to Assess the Efficacy and Safety of AZD4547 monotherapy versus paclitaxel in Patients with Advanced Gastric or Gastro-oesophageal Junction Cancer with FGFR2 Polysomy or Gene Amplification (SHINE study)
- Disease
- oesophageal cancer
- Drug Name
- AZD4547
- Generic Name
- AZD4547
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Jan 18, 1971
- Study Name
- SHINE
- ClinicalTrials.gov ID
- NCT01457846
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
